EFFECTOR Therapeutics Q4 EPS $(3.42) Misses $(1.65) Estimate
EFFECTOR Therapeutics Q4 EPS $(3.42) Misses $(1.65) Estimate
EFFECTOR Therapeutics第四季度每股收益美元(3.42美元)未達到預期(1.65美元)
eFFECTOR Therapeutics (NASDAQ:EFTR) reported quarterly losses of $(3.42) per share which missed the analyst consensus estimate of $(1.65) by 107.27 percent. This is a 37.82 percent increase over losses of $(5.50) per share from the same period last year.
Effector Therapeutics(納斯達克股票代碼:EFTR)公佈的季度虧損爲每股3.42美元(3.42美元),比分析師普遍預期的1.65美元(1.65美元)低107.27%。這比去年同期每股虧損5.50美元(5.50)增長了37.82%。